Catalent, Inc. 3/A SEC Filings

Filed On	Filing
16 Dec 2019	Form 3/A: Grippo Michael J, SVP, Strategy & Corp. Dev. Holds 16,026 shares of Common Stock
05 Nov 2019	Form 3/A: Grippo Michael J, SVP, Strategy & Corp. Dev. No securities owned
18 Sep 2018	Form 3/A: Arnold Jonathan, President, Oral Drug Delivery Holds 28,792 shares of Common Stock
19 Jul 2017	Form 3/A: Dolan Christine, See Remarks Holds 7,837 shares of Common Stock
08 May 2015	Form 3/A: Quella James, Director Holds 6,829 shares of Common Stock
27 Oct 2014	Form 3/A: Gennadios Aristippos, See Remarks

Comments